Biocare Medical

Biocare Medical, founded in 1997, has gained prominence in the biotechnology and healthcare industries, emphasizing its commitment to "Fighting Cancer, One Slide at a Time." The company specializes in automated immunohistochemistry (IHC) instrumentation and a comprehensive range of reagents for IHC and in situ hybridization (ISH; RISH) testing. It has notably pioneered multiplex IHC detection, offering efficiency improvements such as accelerated turnaround time, enhanced instrument productivity, and up to a 50% reduction in reagent consumption and cost. The intelliPATH FLX, its groundbreaking product, is the sole entirely open, continuous random access IHC instrument in existence. This innovation has been well-received by a diverse clientele including histology laboratories, pharmaceutical and biotechnology companies, CROs, and academic, government, and military labs, operating globally. The recent Private Equity Round investment by GHO Capital in 02 December 2021 underscores external validation of Biocare Medical's potential. With headquarters and manufacturing facilities located in Concord, Calif., the company has effectively established a global distribution network and continues to expand its product portfolio for the burgeoning cancer and infectious disease diagnostic and research markets. Biocare Medical stands out in its dedication to innovation and its determination to make a meaningful impact in combating cancer. For further details, visit biocare.net and slidestainer.com.